<乌鸦传媒>Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
<乌鸦传媒>Checkpoints Show Different Outcomes in Breast Cancer Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
<乌鸦传媒>T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancer Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
<乌鸦传媒>Edging Closer to OS Benefit With Novel Anti-HER2 Drug Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
<乌鸦传媒>New Standard for Metastatic HER2 Breast Cancer Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
<乌鸦传媒>Survival Bump With Oral AML Maintenance Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients Dec 10, 2019
<乌鸦传媒>Docetaxel First May Boost Survival in mCRPC Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
<乌鸦传媒>IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
<乌鸦传媒>FCR Still an Option in IGHV-Unmutated CLL? Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit Oct 08, 2019
<乌鸦传媒>Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
<乌鸦传媒>Ibrutinib's Cardiotoxicity Comes Into Focus Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
<乌鸦传媒>Tx Deintensification Wins in Head and Neck Cancer, But ... Only against another less-intensive approach in HPV-positive disease Sep 18, 2019
<乌鸦传媒>'Dirtier' Drugs Step Aside in RET-Positive NSCLC Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
<乌鸦传媒>Total Chemo Dose Still Matters in Breast Cancer Worse survival with cumulative dose Aug 20, 2019
<乌鸦传媒>Depth of Tumor Response a Better Survival Predictor Could improve on RECIST as outcome measure in oncology Jun 05, 2019
<乌鸦传媒>Omitting Chemo Feasible in First-Line HER2+ Breast Cancer? De-escalation showed mixed results in metastatic disease May 01, 2019
<乌鸦传媒>'Magic Mouthwash' Little Help for Radiation-Induced Mucositis Only statistical improvements in pain scores for head and neck cancer patients Apr 16, 2019
<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<乌鸦传媒>PARP Inhibitor Maintenance for Pancreatic Cancer Study takes cue from new treatment paradigm in BRCA-mutant ovarian cancer Apr 03, 2019
<乌鸦传媒>Reversing Melanoma Resistance to Immunotherapy HDAC inhibitor/anti-PD-1 combo active after initial anti-PD-1 failure Apr 02, 2019 video
<乌鸦传媒>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<乌鸦传媒>Aggressive Tx Remains Common for Adults, Children Near Death Many patients continue with treatments they probably don't need Mar 30, 2019
<乌鸦传媒>Early Data Send Strong Signal in Advanced Gyn Cancers Clinical benefit rate tops 90% in pair of single-center studies Mar 19, 2019
<乌鸦传媒>When PARP Inhibitors Fail in Ovarian Cancer Study identifies subgroup for whom another go could be worthwhile Mar 18, 2019
<乌鸦传媒>Avelumab Combo Falls Short in Advanced Ovarian Ca But showed promise in PD-L1-positive group Mar 18, 2019
<乌鸦传媒>Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVD Increased hospitalizations seen among all abiraterone-treated patients Feb 27, 2019
<乌鸦传媒>Genetic Profiling Disappoints for CUP Survival But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
<乌鸦传媒>Surgery/HIPEC Safer Than Other High-Risk Cancer Procedures Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<乌鸦传媒>Visual Guide to AVERT's VTE Prevention in Cancer Apixaban effective against important chemotherapy side effect Dec 07, 2018
<乌鸦传媒>Low-Dose Tamoxifen Feasible Option in Breast Cancer Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<乌鸦传媒>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Ca Cetuximab resulted in more patient deaths across U.S., German studies Oct 23, 2018
<乌鸦传媒>Study: Paclitaxel Best for HIV-Related Kaposi's Sarcoma Other chemotherapies fall behind in resource-limited setting Jul 29, 2018
<乌鸦传媒>Is Drug Vial Optimization in Peril? Pharmacy Practice News Also, how to advance your leadership skills Jun 20, 2018
<乌鸦传媒>Ditching Chemo Appears Viable in Frontline Follicular Lymphoma PFS 'nearly identical' at 3 years with novel immunomodulatory combination Jun 06, 2018
<乌鸦传媒>PFS Rises in Ovarian Ca with Repeat Bevacizumab Magnitude of benefit similar to first-line therapy Jun 06, 2018
<乌鸦传媒>Many with Metastatic Kidney Cancer Can Skip Surgery Overall survival with single-agent sunitinib better than with resection Jun 04, 2018
<乌鸦传媒>Hot Chemo Fails in Rare Cancer HIPEC and surgery equals surgery alone in peritoneal carcinomatosis Jun 04, 2018 video
<乌鸦传媒>Rare Childhood Cancer Gets First Tx Advance in 30 Years But impact unclear for U.S. rhabdomyosarcoma patients Jun 04, 2018
